Recombinant humanized monoclonal antibody to CD19.
Applications
ELISA, FACS, Functional Assay, In Vivo
Reactivity
Human, Mouse
Host
Humanized
Clonality
Monoclonal
Isotype
IgG1
Light Chains
kappa
Conjugate
Unconjugated
Purification
Protein A affinity chromatography.
Concentration
Reconstitution dependent.
Molecular Weight
This antibody has a predicted MW of 146.5 kDa.
Purity
> 95% (by SDS-PAGE).
Product Form
Lyophilized
Reconstitution
Reconstitute with 100µl of sterile double-distilled water to bring antibody to 1mg/ml concentration. Gently shake to solubilize completely. Do not vortex!
Formulation
Lyophilized from 25mM Histadine, pH 6.2, with 8% Sucrose and 0.01% Tween80.
Storage
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
SDS-PAGE analysis of Inebilizumab Biosimilar - Anti-CD19 Antibody - Low endotoxin, Azide free (A323509) under reducing (R) conditions confirms that the purity of this antibody is greater than 95%.
Publishing research using Inebilizumab Biosimilar - Anti-CD19 Antibody - Low endotoxin, Azide free (A323509)? Please let us know so that we can list the citation on this page.
Alternative products to Inebilizumab Biosimilar - Anti-CD19 Antibody - Low endotoxin, Azide free (A323509)